Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis

M Gadgeel, B AlQanber, S Buck, JW Taub… - Annals of …, 2021 - Springer
Children with Down syndrome (DS) are at an increased risk of developing transient
abnormal myelopoiesis (TAM) and acute leukemia. Aberrant expression of CD56 has been …
被引用次数：5 相关文章

Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis

M Gadgeel, B AlQanber, S Buck… - Annals of …, 2021 - pubmed.ncbi.nlm.nih.gov
Children with Down syndrome (DS) are at an increased risk of developing transient
abnormal myelopoiesis (TAM) and acute leukemia. Aberrant expression of CD56 has been …

Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis.

M Gadgeel, B AlQanber, S Buck, JW Taub… - Annals of …, 2021 - europepmc.org
Children with Down syndrome (DS) are at an increased risk of developing transient
abnormal myelopoiesis (TAM) and acute leukemia. Aberrant expression of CD56 has been …

Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis

G Manisha, AQ Batool, S Buck, JW Taub… - Annals of …, 2021 - search.proquest.com
Children with Down syndrome (DS) are at an increased risk of developing transient
abnormal myelopoiesis (TAM) and acute leukemia. Aberrant expression of CD56 has been …